Back to Endocrinology
Endocrinologyv2018Evidence-Based

Metabolic Score for Insulin Resistance (METS-IR)

Predicts risk of type 2 diabetes in previously undiagnosed patients using fasting glucose, triglycerides, BMI, and HDL cholesterol. A simple, non-insulin dependent marker for insulin resistance.

Clinical Input Parameters

mg/dL
Range: 40 — 700 mg/dL
mg/dL
Range: 10 — 2000 mg/dL
kg/m²
Range: 10 — 70 kg/m²
mg/dL
Range: 10 — 200 mg/dL
Clinical Assessment
Awaiting Parameters
mets ir score
—Points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Metabolic Score for Insulin Resistance (METS-IR) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within endocrinology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

METS-IR = (ln((2 × Fasting Glucose) + Triglycerides) × BMI) / ln(HDL Cholesterol)

Clinical Pearls & Practice Notes

  • Ideal for use in outpatient and primary care settings
  • Does not require insulin measurements, making it more practical than HOMA-IR
  • Validated primarily in Mexican and Asian populations
  • Not a diagnostic tool for T2DM but a risk assessment tool
  • All measurements should be taken in fasting state
  • May need further validation in other ethnic populations

Evidence & Literature Citations

  1. Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018 May;178(5):533-544.
  2. Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vázquez A, et al. Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health. Clin Nutr. 2020 May;39(5):1613-1621.
  3. Zhang M, Liu D, Qin P, et al. Association of metabolic score for insulin resistance and its 6-year change with incident type 2 diabetes mellitus. J Diabetes. 2021 Sep;13(9):725-734.

Score Interpretation Ranges

Low Risk0 – 50.39 pts

METS-IR ≤50.39

High Risk50.39 – 999 pts

METS-IR >50.39

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.